CN110973611A - Special medical application formula food for hepatitis patients and preparation method thereof - Google Patents
Special medical application formula food for hepatitis patients and preparation method thereof Download PDFInfo
- Publication number
- CN110973611A CN110973611A CN201911377634.8A CN201911377634A CN110973611A CN 110973611 A CN110973611 A CN 110973611A CN 201911377634 A CN201911377634 A CN 201911377634A CN 110973611 A CN110973611 A CN 110973611A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- special medical
- formula food
- hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 57
- 231100000283 hepatitis Toxicity 0.000 title claims abstract description 57
- 235000013305 food Nutrition 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- 239000000843 powder Substances 0.000 claims abstract description 94
- 229920001661 Chitosan Polymers 0.000 claims abstract description 30
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000000284 extract Substances 0.000 claims abstract description 29
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229960004949 glycyrrhizic acid Drugs 0.000 claims abstract description 29
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000001685 glycyrrhizic acid Substances 0.000 claims abstract description 29
- 235000019410 glycyrrhizin Nutrition 0.000 claims abstract description 29
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 29
- 241000411851 herbal medicine Species 0.000 claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract description 29
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 28
- 150000004676 glycans Chemical class 0.000 claims abstract description 28
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 28
- 239000005017 polysaccharide Substances 0.000 claims abstract description 28
- 241000196324 Embryophyta Species 0.000 claims abstract description 16
- 239000002131 composite material Substances 0.000 claims abstract description 16
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 16
- 239000011707 mineral Substances 0.000 claims abstract description 16
- 235000019152 folic acid Nutrition 0.000 claims abstract description 15
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229960000304 folic acid Drugs 0.000 claims abstract description 14
- 239000011724 folic acid Substances 0.000 claims abstract description 14
- 244000226021 Anacardium occidentale Species 0.000 claims abstract description 12
- 241001107116 Castanospermum australe Species 0.000 claims abstract description 12
- 244000060011 Cocos nucifera Species 0.000 claims abstract description 12
- 235000013162 Cocos nucifera Nutrition 0.000 claims abstract description 12
- 235000021279 black bean Nutrition 0.000 claims abstract description 12
- 235000020226 cashew nut Nutrition 0.000 claims abstract description 12
- 241000134400 Cotinus coggygria Species 0.000 claims abstract description 9
- 241001180472 Iris japonica Species 0.000 claims abstract description 9
- 239000004575 stone Substances 0.000 claims abstract description 9
- 241000208278 Hyoscyamus Species 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 8
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 7
- 241001289529 Fallopia multiflora Species 0.000 claims abstract description 7
- 241000054262 Cassytha capillaris Species 0.000 claims abstract description 6
- 240000000163 Cycas revoluta Species 0.000 claims abstract description 4
- 235000008601 Cycas revoluta Nutrition 0.000 claims abstract description 4
- 235000010804 Maranta arundinacea Nutrition 0.000 claims abstract description 4
- 235000012419 Thalia geniculata Nutrition 0.000 claims abstract description 4
- 244000151018 Maranta arundinacea Species 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims description 24
- 239000003960 organic solvent Substances 0.000 claims description 16
- 235000010755 mineral Nutrition 0.000 claims description 15
- 238000009472 formulation Methods 0.000 claims description 9
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 claims description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 8
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 239000001506 calcium phosphate Substances 0.000 claims description 8
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 8
- 235000011010 calcium phosphates Nutrition 0.000 claims description 8
- 229940108925 copper gluconate Drugs 0.000 claims description 8
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 8
- 239000004222 ferrous gluconate Substances 0.000 claims description 8
- 229960001645 ferrous gluconate Drugs 0.000 claims description 8
- 235000013924 ferrous gluconate Nutrition 0.000 claims description 8
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 229910052711 selenium Inorganic materials 0.000 claims description 8
- 239000011669 selenium Substances 0.000 claims description 8
- 239000001509 sodium citrate Substances 0.000 claims description 8
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 8
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 8
- 241000700608 Sagitta Species 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- 229960001714 calcium phosphate Drugs 0.000 claims description 4
- 238000010411 cooking Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 4
- 235000019797 dipotassium phosphate Nutrition 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 239000008518 lycium barbarum polysaccharide Substances 0.000 claims description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 4
- 238000002390 rotary evaporation Methods 0.000 claims description 4
- 229940091258 selenium supplement Drugs 0.000 claims description 4
- 229960001790 sodium citrate Drugs 0.000 claims description 4
- 235000011083 sodium citrates Nutrition 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 240000002900 Arthrospira platensis Species 0.000 claims description 3
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 3
- 241000405911 Rehmannia glutinosa Species 0.000 claims description 3
- 244000237330 gutta percha tree Species 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 229940082787 spirulina Drugs 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 230000000311 effect on hepatitis Effects 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 4
- 230000000052 comparative effect Effects 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 241000218916 Cycas Species 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000037208 balanced nutrition Effects 0.000 description 4
- 235000019046 balanced nutrition Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 235000006463 Brassica alba Nutrition 0.000 description 3
- 244000140786 Brassica hirta Species 0.000 description 3
- 241000518307 Cassytha Species 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 239000012676 herbal extract Substances 0.000 description 3
- 238000011031 large-scale manufacturing process Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 2
- 235000011371 Brassica hirta Nutrition 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 240000001341 Reynoutria japonica Species 0.000 description 2
- 235000018167 Reynoutria japonica Nutrition 0.000 description 2
- 244000145580 Thalia geniculata Species 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 240000009132 Sagittaria sagittifolia Species 0.000 description 1
- 235000006466 Sagittaria sagittifolia Nutrition 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 150000002224 folic acids Chemical class 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a special medical application formula food for hepatitis patients, which is characterized by comprising the following components in parts by weight: 0.1-0.3 part of folic acid, 10-15 parts of glycyrrhizic acid modified hyperbranched chitosan, 2-5 parts of plant polysaccharide, 5-10 parts of arrowroot powder, 3-6 parts of coconut powder, 15-20 parts of black bean powder, 0.1-0.3 part of composite mineral powder, 3-6 parts of cashew nut powder, 6-10 parts of yam powder and 3-5 parts of Chinese herbal medicine extract. The Chinese herbal medicine extract is prepared from the following raw materials in parts by weight: 3-7 parts of polygonum multiflorum, 4-8 parts of cycas revoluta, 4-8 parts of cotinus coggygria root, 2-5 parts of iris japonica, 3-7 parts of henbane, 2-6 parts of medical stone, 4-8 parts of cassytha filiformis, 1-3 parts of semen brassicae and 2-5 parts of angelica sinensis. The invention also discloses a preparation method of the formula food for special medical application for the hepatitis patients. The special medical application formula food for the hepatitis patients disclosed by the invention is rich, sufficient and balanced in nutrition, good in auxiliary curative effect on hepatitis, good in taste and easy to absorb by human bodies.
Description
Technical Field
The invention relates to the technical field of formula foods with special medical applications, in particular to a formula food with special medical applications for hepatitis patients and a preparation method thereof.
Background
In recent years, with the acceleration of the pace of life and the increase of life and working pressure in modern society, various daily meals are regularly taken at home after working overnight and irregular diet. At the moment, people are easily infected by virus, in addition, a series of liver diseases such as alcoholic liver, fatty liver, hepatitis B, liver cancer and the like are caused by the damage of long-term drinking, drug poisoning, low immunity of the organism and metabolic disorder of the organism to the liver, and the health of people is seriously influenced, wherein the more common liver disease is hepatitis, which brings a lot of troubles to the life, work and study of people and brings great economic burden and physiological pain to patients. Therefore, it is very urgent to select an appropriate hepatitis treatment scheme.
The liver is one of the most important organs in the digestive system of the human body, is the only organ for metabolizing and detoxifying nutrients, toxins and drugs from portal circulation and arterial blood supply, and bears various metabolic processes of proteins, fats, carbohydrates and the like of the human body, and can synthesize plasma, non-essential amino acids, glycogen and insulin-like growth factors, and also synthesize, activate and store various vitamins in the liver, liver cells are the main storage bank of vitamin A, some wastes of human body metabolism can be safely discharged out of the body after being transformed and detoxified by the liver, such as discharging ammonia in the form of synthetic urea, bile secreted from the liver plays an important role in fat digestion and absorption in the intestinal tract, and the main site of fat metabolism is in the liver. The liver also has strong regeneration function and function reserve, and can maintain normal function as long as more than 20 percent of normal cells exist, but when the liver is damaged, the liver cannot perform various metabolic functions to ensure the absorption and transformation of nutrition, and various nutritional problems are accompanied. At present, the method for treating hepatitis is limited, mainly some enzyme-reducing medicines and lipid-lowering medicines are taken, and some secondary diseases such as heart and kidney function decline can be caused by long-term taking of the enzyme-reducing medicines and the lipid-lowering medicines. The first method for improving liver functions is mainly prevention, such as supplementing food containing more vitamins B, C, K and folic acids, providing high-quality protein and the like. Therefore, the food therapy has the effect of helping to treat the hepatitis.
The formula food for special medical application is specially processed and prepared for meeting the special requirements of people with limited food intake, digestive absorption disorder, metabolic disorder or specific disease states on nutrients or diet. The product must be eaten alone or in combination with other foods under the guidance of doctors or clinical dieticians. The formula food for special medical application is only one way of providing nutrition support for clinical patients, and provides a selection mode for clinical nutrition support. The current formula food for special medical use for hepatitis patients is only suitable for specific types of hepatitis patients, and has poor effect on other types of hepatitis patients; the composition of the product is more inclined to western dietary habits, the formula food with special medical application is less for hepatitis patients with the dietary habits of Chinese population, the products on the market are mainly in an integral protein type or short peptide type and mostly are single active ingredients, the main functions are to remove free radicals, improve chemical liver injury and the like, the nutritional requirements of patients with hepatic encephalopathy and fatty liver cannot be met, and the cost and the high selling price of the products exceed the economic bearing capacity of most of the population.
Therefore, the development of the special medical application formula food for the hepatitis patients, which has the advantages of low price, rich and balanced nutrition, good auxiliary curative effect on hepatitis, good taste and easy absorption by human bodies, meets the market demand, has wide market value and application prospect, and has very important significance for promoting the treatment of hepatitis and the development of the special medical application formula food.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide the formula food with special medical application for the hepatitis patient and the preparation method thereof, the preparation method is simple and easy to implement, has low requirements on equipment, low cost, high preparation efficiency and yield, and is suitable for continuous large-scale production; the prepared formula food for the patients with hepatitis has rich, sufficient and balanced nutrition, good auxiliary curative effect on hepatitis, good taste and easy absorption by human bodies.
In order to achieve the purpose, the invention adopts the technical scheme that:
the formula food for special medical application for hepatitis patients is characterized by comprising the following components in parts by weight: 0.1-0.3 part of folic acid, 10-15 parts of glycyrrhizic acid modified hyperbranched chitosan, 2-5 parts of plant polysaccharide, 5-10 parts of arrowroot powder, 3-6 parts of coconut powder, 15-20 parts of black bean powder, 0.1-0.3 part of composite mineral powder, 3-6 parts of cashew nut powder, 6-10 parts of yam powder and 3-5 parts of Chinese herbal medicine extract.
Preferably, the formula food for special medical application for the hepatitis patient is characterized by comprising the following steps: 0.2 part of folic acid, 13 parts of glycyrrhizic acid modified hyperbranched chitosan, 3 parts of plant polysaccharide, 7 parts of sagitta powder, 4 parts of coconut powder, 17 parts of black bean powder, 0.2 part of composite mineral powder, 4 parts of cashew powder, 8 parts of yam powder and 4 parts of Chinese herbal medicine extract.
Preferably, the Chinese herbal medicine extract is prepared from the following raw materials in parts by weight: 3-7 parts of polygonum multiflorum, 4-8 parts of cycas revoluta, 4-8 parts of cotinus coggygria root, 2-5 parts of iris japonica, 3-7 parts of henbane, 2-6 parts of medical stone, 4-8 parts of cassytha filiformis, 1-3 parts of semen brassicae and 2-5 parts of angelica sinensis.
Preferably, the preparation method of the Chinese herbal medicine extract comprises the following steps: the preparation method comprises the steps of uniformly mixing the raw materials, grinding and sieving the mixture through a 100-mesh and 300-mesh sieve to form raw material powder, adding the raw material powder into water with the mass 5-10 times of that of the raw material powder, cooking the mixture for 3-5 hours at 95-100 ℃, and then sequentially filtering and concentrating the mixture to prepare the powder to obtain the Chinese herbal medicine extract.
Preferably, the composite mineral powder comprises dipotassium hydrogen phosphate, sodium citrate, calcium phosphate, ferrous gluconate, copper gluconate and selenium-enriched yeast.
Preferably, the mass ratio of the dipotassium phosphate, the sodium citrate, the calcium phosphate, the ferrous gluconate, the copper gluconate and the selenium-enriched yeast is 1:1:1:0.5 (0.1-0.3) to 0.3-0.6.
Preferably, the plant polysaccharide is at least one of lycium barbarum polysaccharide, spirulina polysaccharide, eucommia ulmoides polysaccharide, fig polysaccharide and rehmannia glutinosa polysaccharide.
Preferably, the preparation method of the glycyrrhizic acid modified hyperbranched chitosan comprises the following steps: adding glycyrrhizic acid and hyperbranched chitosan into an organic solvent, stirring and reacting for 4-6 hours at 40-50 ℃, and then performing rotary evaporation to remove the organic solvent to obtain the glycyrrhizic acid modified hyperbranched chitosan.
Preferably, the mass ratio of the glycyrrhizic acid to the hyperbranched chitosan to the organic solvent is 1 (2-3).
Preferably, the organic solvent is one of tetrahydrofuran, N-dimethylformamide and acetone.
Another object of the present invention is to provide a method for preparing a formula food for special medical use for patients with hepatitis, which comprises the following steps: respectively pulverizing and sieving the components, weighing according to the weight parts, uniformly mixing, baking in an oven, cooling to room temperature, sterilizing in steam at 87-98 deg.C, and packaging.
Preferably, the turning-over baking temperature is 60-80 ℃, and the turning-over baking time is 15-25 min.
Due to the application of the technical scheme, compared with the prior art, the invention has the following advantages: the invention discloses a special medical application formula food for hepatitis patients and a preparation method thereof, wherein the preparation method is simple and easy to implement, has low requirements on equipment, low cost, high preparation efficiency and high yield, and is suitable for continuous large-scale production; the prepared formula food for the patients with hepatitis has rich, sufficient and balanced nutrition, good auxiliary curative effect on hepatitis, good taste and easy absorption by human bodies.
Detailed Description
The invention relates to a special medical application formula food for hepatitis patients, which is characterized by comprising the following components in parts by weight: 0.1-0.3 part of folic acid, 10-15 parts of glycyrrhizic acid modified hyperbranched chitosan, 2-5 parts of plant polysaccharide, 5-10 parts of arrowroot powder, 3-6 parts of coconut powder, 15-20 parts of black bean powder, 0.1-0.3 part of composite mineral powder, 3-6 parts of cashew nut powder, 6-10 parts of yam powder and 3-5 parts of Chinese herbal medicine extract.
Preferably, the formula food for special medical application for the hepatitis patient is characterized by comprising the following steps: 0.2 part of folic acid, 13 parts of glycyrrhizic acid modified hyperbranched chitosan, 3 parts of plant polysaccharide, 7 parts of sagitta powder, 4 parts of coconut powder, 17 parts of black bean powder, 0.2 part of composite mineral powder, 4 parts of cashew powder, 8 parts of yam powder and 4 parts of Chinese herbal medicine extract.
Preferably, the Chinese herbal medicine extract is prepared from the following raw materials in parts by weight: 3-7 parts of polygonum multiflorum, 4-8 parts of cycas revoluta, 4-8 parts of cotinus coggygria root, 2-5 parts of iris japonica, 3-7 parts of henbane, 2-6 parts of medical stone, 4-8 parts of cassytha filiformis, 1-3 parts of semen brassicae and 2-5 parts of angelica sinensis.
Preferably, the preparation method of the Chinese herbal medicine extract comprises the following steps: the preparation method comprises the steps of uniformly mixing the raw materials, grinding and sieving the mixture through a 100-mesh and 300-mesh sieve to form raw material powder, adding the raw material powder into water with the mass 5-10 times of that of the raw material powder, cooking the mixture for 3-5 hours at 95-100 ℃, and then sequentially filtering and concentrating the mixture to prepare the powder to obtain the Chinese herbal medicine extract.
Preferably, the composite mineral powder comprises dipotassium hydrogen phosphate, sodium citrate, calcium phosphate, ferrous gluconate, copper gluconate and selenium-enriched yeast.
Preferably, the mass ratio of the dipotassium phosphate, the sodium citrate, the calcium phosphate, the ferrous gluconate, the copper gluconate and the selenium-enriched yeast is 1:1:1:0.5 (0.1-0.3) to 0.3-0.6.
Preferably, the plant polysaccharide is at least one of lycium barbarum polysaccharide, spirulina polysaccharide, eucommia ulmoides polysaccharide, fig polysaccharide and rehmannia glutinosa polysaccharide.
Preferably, the preparation method of the glycyrrhizic acid modified hyperbranched chitosan comprises the following steps: adding glycyrrhizic acid and hyperbranched chitosan into an organic solvent, stirring and reacting for 4-6 hours at 40-50 ℃, and then performing rotary evaporation to remove the organic solvent to obtain the glycyrrhizic acid modified hyperbranched chitosan.
Preferably, the mass ratio of the glycyrrhizic acid to the hyperbranched chitosan to the organic solvent is 1 (2-3).
Preferably, the organic solvent is one of tetrahydrofuran, N-dimethylformamide and acetone.
Another object of the present invention is to provide a method for preparing a formula food for special medical use for patients with hepatitis, which comprises the following steps: respectively pulverizing and sieving the components, weighing according to the weight parts, uniformly mixing, baking in an oven, cooling to room temperature, sterilizing in steam at 87-98 deg.C, and packaging.
Preferably, the turning-over baking temperature is 60-80 ℃, and the turning-over baking time is 15-25 min.
Due to the application of the technical scheme, compared with the prior art, the invention has the following advantages: the invention discloses a special medical application formula food for hepatitis patients and a preparation method thereof, wherein the preparation method is simple and easy to implement, has low requirements on equipment, low cost, high preparation efficiency and high yield, and is suitable for continuous large-scale production; the prepared formula food for the patients with hepatitis has rich, sufficient and balanced nutrition, good auxiliary curative effect on hepatitis, good taste and easy absorption by human bodies.
The invention will be further described with reference to specific examples, but the scope of protection of the invention is not limited thereto:
example 1
The embodiment provides a formula food for special medical application for a hepatitis patient, which is characterized by comprising the following steps: 0.2 part of folic acid, 13 parts of glycyrrhizic acid modified hyperbranched chitosan, 3 parts of plant polysaccharide, 7 parts of sagitta powder, 4 parts of coconut powder, 17 parts of black bean powder, 0.2 part of composite mineral powder, 4 parts of cashew powder, 8 parts of yam powder and 4 parts of Chinese herbal medicine extract.
The Chinese herbal medicine extract is prepared from the following raw materials in parts by weight: 3 parts of polygonum multiflorum, 4 parts of cycas revolute, 4 parts of cotinus coggygria root, 2 parts of iris japonica, 3 parts of henbane, 2 parts of medical stone, 4 parts of cassytha filiformis, 1 part of semen brassicae and 2 parts of angelica sinensis.
The preparation method of the Chinese herbal medicine extract comprises the following steps: the preparation method comprises the following steps of uniformly mixing the raw materials, grinding and screening the raw materials by a 100-mesh sieve to form raw material powder, adding the raw material powder into water with the mass 5 times of that of the raw material powder, cooking the raw material powder for 3 hours at 95 ℃, filtering the raw material powder in sequence, and concentrating the raw material powder to prepare the Chinese herbal medicine extract.
The composite mineral powder comprises dipotassium hydrogen phosphate, sodium citrate, calcium phosphate, ferrous gluconate, copper gluconate and selenium-enriched yeast; the mass ratio of the dipotassium phosphate to the sodium citrate to the calcium phosphate to the ferrous gluconate to the copper gluconate to the selenium-enriched yeast is 1:1:1:0.5:0.1: 0.3.
The plant polysaccharide is lycium barbarum polysaccharide.
The preparation method of the glycyrrhizic acid modified hyperbranched chitosan comprises the following steps: adding glycyrrhizic acid and hyperbranched chitosan into an organic solvent, stirring and reacting for 4 hours at 40 ℃, and then performing rotary evaporation to remove the organic solvent to obtain glycyrrhizic acid modified hyperbranched chitosan; the mass ratio of the glycyrrhizic acid to the hyperbranched chitosan to the organic solvent is 1: 2; the organic solvent is tetrahydrofuran.
The preparation method of the formula food for special medical application for the hepatitis patient is characterized by comprising the following steps: respectively crushing and sieving the components, weighing the components according to the weight part ratio, uniformly mixing, sending the mixture into an oven for turning over and baking, cooling the mixture to room temperature, sterilizing the mixture in steam at 87 ℃, and subpackaging the mixture to obtain the traditional Chinese medicine composition; the turning and baking temperature is 60 ℃, and the turning and baking time is 15 min.
Example 2
Example 2 provides a special medical use formula food for a hepatitis patient, which is substantially the same as in example 1, except that the special medical use formula food for the hepatitis patient comprises the following components in parts by weight: 0.1 part of folic acid, 10 parts of glycyrrhizic acid modified hyperbranched chitosan, 2 parts of plant polysaccharide, 5 parts of sagitta powder, 3 parts of coconut powder, 15 parts of black bean powder, 0.1 part of composite mineral powder, 3 parts of cashew nut powder, 6 parts of yam powder and 3 parts of Chinese herbal medicine extract. The Chinese herbal medicine extract is prepared from the following raw materials in parts by weight: 3-7 parts of polygonum multiflorum, 4-8 parts of cycas revolute, 4-8 parts of cotinus coggygria root, 2 parts of iris japonica, 3 parts of henbane, 2 parts of medical stone, 4 parts of filliform cassytha herb, 1 part of semen brassicae and 2 parts of angelica sinensis.
Example 3
Example 3 a special medical-use formula food for a hepatitis patient, which is substantially the same as in example 1, except that the special medical-use formula food for a hepatitis patient comprises the following components in parts by weight: 0.15 part of folic acid, 11 parts of glycyrrhizic acid modified hyperbranched chitosan, 2.5 parts of plant polysaccharide, 6 parts of sagitta powder, 4 parts of coconut powder, 16 parts of black bean powder, 0.15 part of composite mineral powder, 4 parts of cashew powder, 7 parts of yam powder and 3.5 parts of Chinese herbal medicine extract. The Chinese herbal medicine extract is prepared from the following raw materials in parts by weight: 4 parts of fleece-flower root, 5 parts of cycas revolute, 5 parts of cotinus coggygria root, 3 parts of iris japonica, 4 parts of jiuxiancao, 3 parts of medical stone, 5 parts of filliform cassytha herb, 1.5 parts of white mustard seed and 3 parts of angelica.
Example 4
Example 4 provides a special medical use formula food for a hepatitis patient, which is substantially the same as in example 1, except that the special medical use formula food for the hepatitis patient comprises the following components in parts by weight: 0.25 part of folic acid, 14 parts of glycyrrhizic acid modified hyperbranched chitosan, 4.5 parts of plant polysaccharide, 9 parts of sagittaria sagittifolia powder, 5.5 parts of coconut powder, 19 parts of black bean powder, 0.25 part of composite mineral powder, 5.5 parts of cashew nut powder, 9 parts of yam powder and 4.5 parts of Chinese herbal medicine extract. The Chinese herbal medicine extract is prepared from the following raw materials in parts by weight: 6 parts of tuber fleeceflower root, 7 parts of cycas revolute, 7 parts of cotinus coggygria root, 4.5 parts of iris japonica, 6 parts of henbane, 5 parts of medical stone, 7 parts of filliform cassytha herb, 2.5 parts of white mustard seed and 4.5 parts of Chinese angelica.
Example 5
Example 5 provides a special medical use formula food for hepatitis patients, which is substantially the same as in example 1, except that the special medical use formula food for hepatitis patients comprises the following components in parts by weight: 0.3 part of folic acid, 15 parts of glycyrrhizic acid modified hyperbranched chitosan, 5 parts of plant polysaccharide, 10 parts of sagitta powder, 6 parts of coconut powder, 20 parts of black bean powder, 0.3 part of composite mineral powder, 6 parts of cashew powder, 10 parts of yam powder and 5 parts of Chinese herbal medicine extract. The Chinese herbal medicine extract is prepared from the following raw materials in parts by weight: 7 parts of polygonum multiflorum, 8 parts of cycas revolute, 8 parts of cotinus coggygria root, 5 parts of iris japonica, 7 parts of henbane, 6 parts of medical stone, 8 parts of cassytha filiformis, 3 parts of semen brassicae and 5 parts of angelica.
Comparative example 1
Comparative example 1 provides a food formulation for special medical use for patients with hepatitis, which has a formulation and a preparation method substantially the same as those of example 1 except that folic acid is not added.
Comparative example 2
Comparative example 2 provides a food formulation for special medical use for hepatitis patients, which formulation and preparation method are substantially the same as those of example 1 except that glycyrrhizic acid-modified hyperbranched chitosan is not added.
Comparative example 3
Comparative example 3 provides a food formulation for special medical use for patients with hepatitis, whose formulation and preparation method are substantially the same as those of example 1 except that no herbal extracts are added.
Comparative example 4
Comparative example 4 provides a food formulation for special medical use for hepatitis patients, which has a formulation and preparation method substantially the same as those of example 1, except that filliform and sinapis alba were not added during the preparation of the herbal extracts.
Clinical trial studies were conducted on the hepatitis patients prepared in examples 1 to 5 and comparative examples 1 to 4 using the foods formulated for special medical use, and the results are shown in Table 1, and the test methods were as follows: 100 hepatitis patients were taken in each of comparative examples 1 to 5 and examples 1 to 4, and the hepatitis patients were eaten with the food formula for special medical use 1 time a day 2 hours after breakfast, 10 g each time, the eating method and the eating amount were the same for each group, and after continuously observing for 15 days, the clinical symptom improvement was observed.
TABLE 1
| Item | Display effect (human) | Invalid (human) | Effective rate (%) |
| Example 1 | 90 | 4 | 96 |
| Example 2 | 92 | 3 | 97 |
| Example 3 | 93 | 3 | 97 |
| Example 4 | 95 | 2 | 98 |
| Example 5 | 96 | 1 | 99 |
| Comparative example 1 | 85 | 10 | 90 |
| Comparative example 2 | 82 | 8 | 92 |
| Comparative example 3 | 80 | 10 | 90 |
| Comparative example 4 | 83 | 11 | 89 |
As can be seen from table 1, the clinical symptom improvement effect of the foods formulated for special medical use for patients with hepatitis in examples 1 to 5 is more remarkable, and it can be seen that folic acid, glycyrrhizic acid modified hyperbranched chitosan, herbal extracts, filliform and semen brassicae are all effective in improving the symptoms of postoperative patients, and the excellent effect of the products of the examples is a result of their synergistic effect.
The above embodiments are merely illustrative of the technical ideas and features of the present invention, and the purpose thereof is to enable those skilled in the art to understand the contents of the present invention and implement the present invention, and not to limit the protection scope of the present invention. All equivalent changes and modifications made according to the spirit of the present invention should be covered within the protection scope of the present invention.
Claims (10)
1. The formula food for special medical application for hepatitis patients is characterized by comprising the following components in parts by weight: 0.1-0.3 part of folic acid, 10-15 parts of glycyrrhizic acid modified hyperbranched chitosan, 2-5 parts of plant polysaccharide, 5-10 parts of arrowroot powder, 3-6 parts of coconut powder, 15-20 parts of black bean powder, 0.1-0.3 part of composite mineral powder, 3-6 parts of cashew nut powder, 6-10 parts of yam powder and 3-5 parts of Chinese herbal medicine extract.
2. The food formulation for special medical use for patients with hepatitis according to claim 1, comprising the steps of: 0.2 part of folic acid, 13 parts of glycyrrhizic acid modified hyperbranched chitosan, 3 parts of plant polysaccharide, 7 parts of sagitta powder, 4 parts of coconut powder, 17 parts of black bean powder, 0.2 part of composite mineral powder, 4 parts of cashew powder, 8 parts of yam powder and 4 parts of Chinese herbal medicine extract.
3. The formula food for special medical use for hepatitis patients according to claim 1, wherein the Chinese herbal medicine extract is prepared from the following raw materials in parts by weight: 3-7 parts of polygonum multiflorum, 4-8 parts of cycas revoluta, 4-8 parts of cotinus coggygria root, 2-5 parts of iris japonica, 3-7 parts of henbane, 2-6 parts of medical stone, 4-8 parts of cassytha filiformis, 1-3 parts of semen brassicae and 2-5 parts of angelica sinensis.
4. The special medical formula food for the hepatitis patients according to claim 3, wherein the preparation method of the Chinese herbal medicine extract comprises the following steps: the preparation method comprises the steps of uniformly mixing the raw materials, grinding and sieving the mixture through a 100-mesh and 300-mesh sieve to form raw material powder, adding the raw material powder into water with the mass 5-10 times of that of the raw material powder, cooking the mixture for 3-5 hours at 95-100 ℃, and then sequentially filtering and concentrating the mixture to prepare the powder to obtain the Chinese herbal medicine extract.
5. The special medical formula food for the hepatitis patients according to claim 1, wherein the composite mineral powder comprises dipotassium hydrogen phosphate, sodium citrate, calcium phosphate, ferrous gluconate, copper gluconate and selenium-enriched yeast; the mass ratio of the dipotassium phosphate, the sodium citrate, the calcium phosphate, the ferrous gluconate, the copper gluconate and the selenium-enriched yeast is 1:1:1:0.5 (0.1-0.3) to 0.3-0.6.
6. The special medical application formula food for the hepatitis patient according to claim 1, wherein the plant polysaccharide is at least one of lycium barbarum polysaccharide, spirulina polysaccharide, eucommia ulmoides polysaccharide, fig polysaccharide and rehmannia glutinosa polysaccharide.
7. The formula food for the special medical application of the hepatitis patient according to claim 1, wherein the preparation method of the glycyrrhizic acid modified hyperbranched chitosan comprises the following steps: adding glycyrrhizic acid and hyperbranched chitosan into an organic solvent, stirring and reacting for 4-6 hours at 40-50 ℃, and then performing rotary evaporation to remove the organic solvent to obtain the glycyrrhizic acid modified hyperbranched chitosan.
8. The formula food for the special medical application of the hepatitis patient according to claim 7, wherein the mass ratio of the glycyrrhizic acid, the hyperbranched chitosan and the organic solvent is 1 (2-3); the organic solvent is one of tetrahydrofuran, N-dimethylformamide and acetone.
9. The special medical use formula food for hepatitis patients according to any one of claims 1 to 8, wherein the preparation method of the special medical use formula food for hepatitis patients comprises the following steps: respectively pulverizing and sieving the components, weighing according to the weight parts, uniformly mixing, baking in an oven, cooling to room temperature, sterilizing in steam at 87-98 deg.C, and packaging.
10. The formula food for special medical use for hepatitis patients according to claim 9, wherein the baking temperature is 60-80 ℃ and the baking time is 15-25 min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911377634.8A CN110973611A (en) | 2019-12-27 | 2019-12-27 | Special medical application formula food for hepatitis patients and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911377634.8A CN110973611A (en) | 2019-12-27 | 2019-12-27 | Special medical application formula food for hepatitis patients and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110973611A true CN110973611A (en) | 2020-04-10 |
Family
ID=70078100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911377634.8A Pending CN110973611A (en) | 2019-12-27 | 2019-12-27 | Special medical application formula food for hepatitis patients and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110973611A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104082737A (en) * | 2014-06-13 | 2014-10-08 | 胡安然 | Instant food for preventing and treating hepatitis |
| CN106605908A (en) * | 2016-05-27 | 2017-05-03 | 韶关邦世迪健康实业有限公司 | Fully nutritional formula product with special medical purposes for liver diseases |
-
2019
- 2019-12-27 CN CN201911377634.8A patent/CN110973611A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104082737A (en) * | 2014-06-13 | 2014-10-08 | 胡安然 | Instant food for preventing and treating hepatitis |
| CN106605908A (en) * | 2016-05-27 | 2017-05-03 | 韶关邦世迪健康实业有限公司 | Fully nutritional formula product with special medical purposes for liver diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1322821C (en) | Natto powder and preparing method and health food containing such natto powder | |
| CN102511800B (en) | Health-care food capsule and preparation method thereof | |
| EP3530277A1 (en) | Chinese medicine healthcare preparations for slimming and weight loss | |
| CN103749982A (en) | Feed for improving egg yield, traditional Chinese medicine additive and preparation method thereof | |
| CN102630858B (en) | Compound pig feed containing Chinese herbal medicine | |
| CN101816425B (en) | Powder mixture of whole American ginseng/giant salamander and preparation method thereof | |
| CN107586672A (en) | A kind of Rosa roxburghii health liquor and preparation method thereof | |
| CN105379973A (en) | Goat feed | |
| CN107213451A (en) | Improve probiotics fermention Chinese medicine preparation of microcirculation in human body obstacle and preparation method thereof | |
| CN111000252A (en) | Fat-reducing and nutrition-balancing meal replacement food and preparation method thereof | |
| CN109349421A (en) | A kind of pigeon for meat growth promotion ecological feed and preparation method thereof | |
| CN101642251B (en) | Nutritive rice suitable for middle-aged and elderly people and processing method thereof | |
| CN109170916A (en) | One kind keeps fit and healthy food compositions and preparation method thereof | |
| CN102090637A (en) | Collagen-containing compound nutritious powder | |
| CN108066384A (en) | A kind of Chinese medicine preparation with strengthen immunity and preparation method thereof | |
| CN104382002A (en) | Maca tablet for alleviating fatigue | |
| CN103238757A (en) | Compound feed containing fermented cottonseed meal for chicken for eggs and preparation method thereof | |
| CN103355412B (en) | Nutrition powder (compound protein milk powder) and preparation method thereof | |
| KR101402852B1 (en) | Fermented bellflower pills and Preparation thereof | |
| CN103005467B (en) | Liver-protecting nutritional composition and liver-protecting nutritional food therefrom | |
| CN110973611A (en) | Special medical application formula food for hepatitis patients and preparation method thereof | |
| CN106036171A (en) | Method for preparing feed for laying hens in growing periods | |
| CN113632903B (en) | Turbid-discharging and beautifying composition and preparation process thereof | |
| CN110547462A (en) | White asparagus lettuce and oat meal replacement powder and preparation method thereof | |
| CN110584099A (en) | Highland barley green juice powder and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200410 |